General Information of Drug Therapeutic Target (DTT) (ID: TT1CN09)

DTT Name HUMAN toll-like receptor 3 (TLR3)
Synonyms CD283
Gene Name TLR3
BioChemical Class
Toll-like receptor
UniProt ID
TLR3_HUMAN
TTD ID
T99834
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Sequence
MRQTLPCIYFWGGLLPFGMLCASSTTKCTVSHEVADCSHLKLTQVPDDLPTNITVLNLTH
NQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFA
FCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSN
NKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEK
LCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQL
EYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHL
NMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKIS
KIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVP
SLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHN
NLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNT
LPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNW
INETHTNIPELSSHYLCNTPPHYHGFPVRLFDTSSCKDSAPFELFFMINTSILLIFIFIV
LLIHFEGWRISFYWNVSVHRVLGFKEIDRQTEQFEYAAYIIHAYKDKDWVWEHFSSMEKE
DQSLKFCLEERDFEAGVFELEAIVNSIKRSRKIIFVITHHLLKDPLCKRFKVHHAVQQAI
EQNLDSIILVFLEEIPDYKLNHALCLRRGMFKSHCILNWPVQKERIGAFRHKLQVALGSK
NSVH
Function
Key component of innate and adaptive immunity. TLRs (Toll-like receptors) control host immune response against pathogens through recognition of molecular patterns specific to microorganisms. TLR3 is a nucleotide-sensing TLR which is activated by double-stranded RNA, a sign of viral infection. Acts via the adapter TRIF/TICAM1, leading to NF-kappa-B activation, IRF3 nuclear translocation, cytokine secretion and the inflammatory response.
KEGG Pathway
Necroptosis (hsa04217 )
Toll-like receptor signaling pathway (hsa04620 )
Hepatitis C (hsa05160 )
Hepatitis B (hsa05161 )
Influenza A (hsa05164 )
Human papillomavirus infection (hsa05165 )
Kaposi sarcoma-associated herpesvirus infection (hsa05167 )
Herpes simplex virus 1 infection (hsa05168 )
Coronavirus disease - COVID-19 (hsa05171 )
Reactome Pathway
Toll Like Receptor 3 (TLR3) Cascade (R-HSA-168164 )
TICAM1, RIP1-mediated IKK complex recruitment (R-HSA-168927 )
RIP-mediated NFkB activation via ZBP1 (R-HSA-1810476 )
TLR3 deficiency - HSE (R-HSA-5602410 )
UNC93B1 deficiency - HSE (R-HSA-5602415 )
TICAM1 deficiency - HSE (R-HSA-5602566 )
TRAF3 deficiency - HSE (R-HSA-5602571 )
TLR3-mediated TICAM1-dependent programmed cell death (R-HSA-9013957 )
TICAM1-dependent activation of IRF3/IRF7 (R-HSA-9013973 )
TICAM1,TRAF6-dependent induction of TAK1 complex (R-HSA-9014325 )
Trafficking and processing of endosomal TLR (R-HSA-1679131 )

Molecular Interaction Atlas (MIA) of This DTT

Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DTT
1 Drugs in Phase 1 Trial Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
Rintatolimod DMSDZ8U Chronic fatigue syndrome 8E49 Phase 1/2 Trial [2]
------------------------------------------------------------------------------------
1 Investigative Agents Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
Polyinosinic:polycytidylic acid DM4VZCW Middle East Respiratory Syndrome (MERS) 1D64 Investigative [3]
------------------------------------------------------------------------------------

References

1 Coronaviruses - drug discovery and therapeutic options. Nat Rev Drug Discov. 2016 May;15(5):327-47.
2 Efficacy of rintatolimod in the treatment of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). Expert Rev Clin Pharmacol. 2016 Jun;9(6):755-70.
3 Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Infection, Immunological Response, and Vaccine Development. J Immunol Res. 2019 Apr 7;2019:6491738. doi: 10.1155/2019/6491738.